Prevalence of Dabigatran-Associated Esophagitis on Upper Gastrointestinal Endoscopy: A Systematic Review and Meta-analysis

Am J Ther. 2023 Sep-Oct;30(5):e496-e498. doi: 10.1097/MJT.0000000000001581.

Authors

Azizullah Beran¹, Mohammed Mhanna², Rami Musallam³, Wasef Sayeh⁴, Ziad Abuhelwa⁴, Sami Ghazaleh⁵, Ragheb Assaly⁴

Affiliations

¹ Division of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN.
² Division of Cardiology, University of Iowa, Iowa City, IA.
³ Department of Internal Medicine, St. Vincent Charity Medical Center, Cleveland, OH.
⁴ Department of Internal Medicine, University of Toledo, Toledo, OH.
⁵ Division of Gastroenterology and Hepatology, University of Toledo, Toledo.

PMID: 37713710
DOI: 10.1097/MJT.0000000000001581

No abstract available

Publication types

Letter
Meta-Analysis
Systematic Review

MeSH terms

Antithrombins / adverse effects
Dabigatran* / adverse effects
Endoscopy, Gastrointestinal
Esophagitis* / chemically induced
Esophagitis* / diagnosis
Esophagitis* / epidemiology
Humans
Prevalence

Substances

Antithrombins
Dabigatran